Sageworth Trust Company of South Dakota’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-42
Closed -$3K – 406
2022
Q2
$3K Hold
42
– – 0.01% 301
2022
Q1
$3K Sell
42
-192
-82% -$10.4K 0.01% 351
2021
Q4
$12K Buy
+234
New +$14.3K 0.02% 328

Other funds holding HAE

Sageworth Trust Company of South Dakota's HAE Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Haemonetics (HAE) in Q3 2022, closing a stake of 42 shares — an estimated $3K sold.

Sageworth Trust Company of South Dakota first reported a position in HAE in Q4 2021 and held it in 3 quarters. The position peaked at $12K in Q4 2021. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Haemonetics position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 42 Haemonetics shares in Q3 2022, an estimated $3K.
  • Sageworth Trust Company of South Dakota first reported a position in Haemonetics in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Haemonetics position peaked at $12K in Q4 2021.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.